Retail Healthcare Sector

Quanterix

Market Cap: US$186.0m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

Y-mAbs Therapeutics

Market Cap: US$185.7m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Pacific Smiles Group

Market Cap: AU$287.7m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

Kodiak Sciences

Market Cap: US$184.2m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Sight Sciences

Market Cap: US$183.5m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

Voyager Therapeutics

Market Cap: US$182.6m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

INmune Bio

Market Cap: US$182.4m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Baird Medical Investment Holdings

Market Cap: US$182.1m

Engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.

OraSure Technologies

Market Cap: US$181.8m

Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.

Electromed

Market Cap: US$180.7m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

Tonix Pharmaceuticals Holding

Market Cap: US$180.2m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

DiaMedica Therapeutics

Market Cap: US$180.0m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Utah Medical Products

Market Cap: US$179.0m

Provides medical devices for the healthcare industry worldwide.

Organigram Global

Market Cap: CA$250.2m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Inhibrx Biosciences

Market Cap: US$178.5m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Stereotaxis

Market Cap: US$178.0m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

enGene Holdings

Market Cap: US$175.9m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Anika Therapeutics

Market Cap: US$174.8m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Spectral Medical

Market Cap: CA$242.3m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Eledon Pharmaceuticals

Market Cap: US$171.9m

Operates as a clinical stage biotechnology company.

TuHURA Biosciences

Market Cap: US$171.2m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

AVITA Medical

Market Cap: US$170.8m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

ProQR Therapeutics

Market Cap: US$170.4m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

scPharmaceuticals

Market Cap: US$170.0m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

AC Immune

Market Cap: US$169.2m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Puma Biotechnology

Market Cap: US$168.3m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Avacta Group

Market Cap: UK£126.5m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Liminatus Pharma

Market Cap: US$167.8m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

Accuray

Market Cap: US$166.9m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

LENSAR

Market Cap: US$166.4m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

TriSalus Life Sciences

Market Cap: US$165.9m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

Zentek

Market Cap: CA$231.6m

Engages in the research and development of graphene and related nanomaterials in Canada.

CVRx

Market Cap: US$165.3m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

Inogen

Market Cap: US$163.7m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.